Neuralink first human patient controls cursor with thought
Elon Musk has announced that the first human recipient of a brain-chip implant from Neuralink has shown remarkable progress, now capable of controlling a computer mouse solely through thought.
During a recent social media event on the X platform, Musk revealed the encouraging news, stating, “Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of. Patient is able to move a mouse around the screen by just thinking.”
Musk further disclosed that Neuralink is actively working to maximize the patient’s ability to execute mouse button clicks through similar neural control.
Despite requests for additional information, Neuralink has yet to respond to inquiries from Reuters.
The achievement follows Neuralink’s successful implantation of a chip in its inaugural human subject last month, marking a significant milestone after obtaining approval for human trial recruitment in September.
Also Read: Musk’s Neuralink implants brain chip in first human
The procedure, as outlined by Neuralink, involves the use of a robotic system to precisely position a brain-computer interface implant within a region of the brain responsible for movement intention. Initial objectives focus on empowering individuals to manipulate a computer cursor or keyboard using cognitive impulses.
Elaborating on Neuralink’s broader objectives, Musk envisions the technology advancing beyond mere cursor control, aiming to streamline surgical insertions of chip devices for treating various conditions such as obesity, autism, depression, and schizophrenia.
While Neuralink’s potential holds promise, concerns over safety protocols have surfaced, prompting calls for scrutiny. Recent reports indicate that the company faced fines for breaching U.S. Department of Transportation regulations concerning the transportation of hazardous materials.
